Telomere length and vascular wall in patients with Type 2 Diabetes Mellitus

Aim. To study the relationship between changes in the artery structure and function and peripheral lymphocyte telomere length in patients with type 2 diabetes mellitus (DM2). Materials and methods. A total of 50 patients with T2DM and without clinical manifestations of cardiovascular disease (C...

Full description

Bibliographic Details
Main Authors: Ekaterina Nailyevna Dudinskaya, Olga Nikolaevna Tkacheva, Marina Vladimirovna Shestakova, Natalya Vasilyevna Brailova, Irina Dmitrievna Strazhesko, Dariga Uaidinichna Akasheva, Olesya Yuryevna Isaykina, Maria Sergeevna Pokrovskaya, Natalya Viktorovna Sharashkina, Sergey Anatolyevich Boytsov
Format: Article
Language:English
Published: Endocrinology Research Centre 2014-09-01
Series:Сахарный диабет
Subjects:
Online Access:https://dia-endojournals.ru/dia/article/viewFile/6620/4647
id doaj-7a4ce1e8bf4e461fb4e465fdc41df7f0
record_format Article
spelling doaj-7a4ce1e8bf4e461fb4e465fdc41df7f02021-06-02T21:37:32ZengEndocrinology Research CentreСахарный диабет2072-03512072-03782014-09-01173313810.14341/DM2014331-386519Telomere length and vascular wall in patients with Type 2 Diabetes MellitusEkaterina Nailyevna Dudinskaya0Olga Nikolaevna Tkacheva1Marina Vladimirovna Shestakova2Natalya Vasilyevna Brailova3Irina Dmitrievna Strazhesko4Dariga Uaidinichna Akasheva5Olesya Yuryevna Isaykina6Maria Sergeevna Pokrovskaya7Natalya Viktorovna Sharashkina8Sergey Anatolyevich Boytsov9National Research Center for Preventive Medicine, MoscowNational Research Center for Preventive Medicine, MoscowEndocrinology Research Centre, MoscowNational Research Center for Preventive Medicine, MoscowNational Research Center for Preventive Medicine, MoscowNational Research Center for Preventive Medicine, MoscowNational Research Center for Preventive Medicine, MoscowNational Research Center for Preventive Medicine, MoscowNational Research Center for Preventive Medicine, MoscowNational Research Center for Preventive Medicine, MoscowAim. To study the relationship between changes in the artery structure and function and peripheral lymphocyte telomere length in patients with type 2 diabetes mellitus (DM2). Materials and methods. A total of 50 patients with T2DM and without clinical manifestations of cardiovascular disease (CVD) were included in the study; the control group consisted of 49 people. The following tests were conducted for all study participants: carbohydrate metabolism evaluation, carotid artery duplex scan to measure intima?media complex thickness (IMT) and to determine the presence of atherosclerotic plaques, carotid?femoral pulse wave velocity (PWV) measurement and lymphocyte telomere length measurement. Results. The vascular changes were more pronounced in patients with T2DM than in controls. The telomeres were shorter in patients with T2DM than in those without diabetes (9.53?0.1 vs 9.86?0.1, p=0.033). The participants were divided according to the telomere length. Among patients with T2DM, there were significant differences in the condition of the vascular wall [PWV: 10.58?0.1 m/s in patients with ?long? telomeres and 15.08?1.3 m/s in patients with ?short? telomeres; IMT: 0.80?0.09 mm in patients with ?long? telomeres and 0.87?0.05 mm in patients with ?short? telomeres (p=0.024)]. There were no significant differences in the arterial structure between the patient and control groups with ?long? telomeres [PWV: 10.58?0.1 m/s vs 10.5?0.5 m/s (p=0.913); IMT: 0.080?0.09 mm vs 0.73?0.03 mm (p=0.12). However, there were significant differences in the vascular wall condition between the patient and control groups with ?short? telomeres [PWV: 15.08?1.3 m/s vs, 10.7?0.5 m/s (p=0.015); IMT: 0.87?0.1 vs 0.78?0.1 (p=0.03)]. Conclusions. The signs of vascular ageing were more pronounced in patients with T2DM than in controls. However, despite diabetes, vascular changes were minimal in patients with ?long? lymphocyte telomeres, comparable with the state of the vascular walls in healthy individuals. Thus, enhanced lymphocyte telomere length may have a protective effect on the vascular wall and may prevent damage from carbohydrate metabolism disorders.https://dia-endojournals.ru/dia/article/viewFile/6620/4647telomere lengthvascular agingdiabetes mellitusinsulin resistance
collection DOAJ
language English
format Article
sources DOAJ
author Ekaterina Nailyevna Dudinskaya
Olga Nikolaevna Tkacheva
Marina Vladimirovna Shestakova
Natalya Vasilyevna Brailova
Irina Dmitrievna Strazhesko
Dariga Uaidinichna Akasheva
Olesya Yuryevna Isaykina
Maria Sergeevna Pokrovskaya
Natalya Viktorovna Sharashkina
Sergey Anatolyevich Boytsov
spellingShingle Ekaterina Nailyevna Dudinskaya
Olga Nikolaevna Tkacheva
Marina Vladimirovna Shestakova
Natalya Vasilyevna Brailova
Irina Dmitrievna Strazhesko
Dariga Uaidinichna Akasheva
Olesya Yuryevna Isaykina
Maria Sergeevna Pokrovskaya
Natalya Viktorovna Sharashkina
Sergey Anatolyevich Boytsov
Telomere length and vascular wall in patients with Type 2 Diabetes Mellitus
Сахарный диабет
telomere length
vascular aging
diabetes mellitus
insulin resistance
author_facet Ekaterina Nailyevna Dudinskaya
Olga Nikolaevna Tkacheva
Marina Vladimirovna Shestakova
Natalya Vasilyevna Brailova
Irina Dmitrievna Strazhesko
Dariga Uaidinichna Akasheva
Olesya Yuryevna Isaykina
Maria Sergeevna Pokrovskaya
Natalya Viktorovna Sharashkina
Sergey Anatolyevich Boytsov
author_sort Ekaterina Nailyevna Dudinskaya
title Telomere length and vascular wall in patients with Type 2 Diabetes Mellitus
title_short Telomere length and vascular wall in patients with Type 2 Diabetes Mellitus
title_full Telomere length and vascular wall in patients with Type 2 Diabetes Mellitus
title_fullStr Telomere length and vascular wall in patients with Type 2 Diabetes Mellitus
title_full_unstemmed Telomere length and vascular wall in patients with Type 2 Diabetes Mellitus
title_sort telomere length and vascular wall in patients with type 2 diabetes mellitus
publisher Endocrinology Research Centre
series Сахарный диабет
issn 2072-0351
2072-0378
publishDate 2014-09-01
description Aim. To study the relationship between changes in the artery structure and function and peripheral lymphocyte telomere length in patients with type 2 diabetes mellitus (DM2). Materials and methods. A total of 50 patients with T2DM and without clinical manifestations of cardiovascular disease (CVD) were included in the study; the control group consisted of 49 people. The following tests were conducted for all study participants: carbohydrate metabolism evaluation, carotid artery duplex scan to measure intima?media complex thickness (IMT) and to determine the presence of atherosclerotic plaques, carotid?femoral pulse wave velocity (PWV) measurement and lymphocyte telomere length measurement. Results. The vascular changes were more pronounced in patients with T2DM than in controls. The telomeres were shorter in patients with T2DM than in those without diabetes (9.53?0.1 vs 9.86?0.1, p=0.033). The participants were divided according to the telomere length. Among patients with T2DM, there were significant differences in the condition of the vascular wall [PWV: 10.58?0.1 m/s in patients with ?long? telomeres and 15.08?1.3 m/s in patients with ?short? telomeres; IMT: 0.80?0.09 mm in patients with ?long? telomeres and 0.87?0.05 mm in patients with ?short? telomeres (p=0.024)]. There were no significant differences in the arterial structure between the patient and control groups with ?long? telomeres [PWV: 10.58?0.1 m/s vs 10.5?0.5 m/s (p=0.913); IMT: 0.080?0.09 mm vs 0.73?0.03 mm (p=0.12). However, there were significant differences in the vascular wall condition between the patient and control groups with ?short? telomeres [PWV: 15.08?1.3 m/s vs, 10.7?0.5 m/s (p=0.015); IMT: 0.87?0.1 vs 0.78?0.1 (p=0.03)]. Conclusions. The signs of vascular ageing were more pronounced in patients with T2DM than in controls. However, despite diabetes, vascular changes were minimal in patients with ?long? lymphocyte telomeres, comparable with the state of the vascular walls in healthy individuals. Thus, enhanced lymphocyte telomere length may have a protective effect on the vascular wall and may prevent damage from carbohydrate metabolism disorders.
topic telomere length
vascular aging
diabetes mellitus
insulin resistance
url https://dia-endojournals.ru/dia/article/viewFile/6620/4647
work_keys_str_mv AT ekaterinanailyevnadudinskaya telomerelengthandvascularwallinpatientswithtype2diabetesmellitus
AT olganikolaevnatkacheva telomerelengthandvascularwallinpatientswithtype2diabetesmellitus
AT marinavladimirovnashestakova telomerelengthandvascularwallinpatientswithtype2diabetesmellitus
AT natalyavasilyevnabrailova telomerelengthandvascularwallinpatientswithtype2diabetesmellitus
AT irinadmitrievnastrazhesko telomerelengthandvascularwallinpatientswithtype2diabetesmellitus
AT darigauaidinichnaakasheva telomerelengthandvascularwallinpatientswithtype2diabetesmellitus
AT olesyayuryevnaisaykina telomerelengthandvascularwallinpatientswithtype2diabetesmellitus
AT mariasergeevnapokrovskaya telomerelengthandvascularwallinpatientswithtype2diabetesmellitus
AT natalyaviktorovnasharashkina telomerelengthandvascularwallinpatientswithtype2diabetesmellitus
AT sergeyanatolyevichboytsov telomerelengthandvascularwallinpatientswithtype2diabetesmellitus
_version_ 1721400469486567424